Patent · US Active

Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infection

US11491198B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

SUN YAT-SEN UNIVERSITY · CN

Inventors

Weiwei Su · Shenyang, CN
Chong Liu · Longbeilingcun, CN
Qian Zhou · Beijing, CN
Peibo Li · Tangxia, CN
Wei Peng · Port Aransas, US
Yonggang Wang · Beijing, CN

Key dates

Filing date	Dec 21, 2020
Grant date	Nov 8, 2022
Priority date	—
Expiry date	Jun 2, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a new drug application of a Pithecellobium clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter baumannii (MDRAB), an MDR Pseudomonas aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli (ECO) and an ESBL-producing Klebsiella pneumonia (KPN).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.